cocamidopropyl hydroxysultaine est-il sûr pendant la grossesse ?
No harmonised reproductive classification or SCCS/CIR repro flag was identified. Repeated-dose/oral (OECD 422) studies reported a developmental/reproductive NOAEL around 300 mg/kg/day and agencies reviewing the data (registration dossiers / national assessments) concluded no developmental toxicity at doses ≤300 mg/kg/day, so there is no evidence of a reproductive hazard. For topical cosmetic use systemic absorption is expected to be low but measurable, so exposure is scored as low (e=1). Sources: ECHA registration dossier and national assessment. (ECHA OECD 422 dossier; Canada final assessment).
Pregnancy-safe products containing cocamidopropyl hydroxysultaine










Related ingredients
Frequently asked questions
- cocamidopropyl hydroxysultaine est-il sûr pendant la grossesse ?
- No harmonised reproductive classification or SCCS/CIR repro flag was identified. Repeated-dose/oral (OECD 422) studies reported a developmental/reproductive NOAEL around 300 mg/kg/day and agencies reviewing the data (registration dossiers / national assessments) concluded no developmental toxicity at doses ≤300 mg/kg/day, so there is no evidence of a reproductive hazard. For topical cosmetic use systemic absorption is expected to be low but measurable, so exposure is scored as low (e=1). Sources: ECHA registration dossier and national assessment. (ECHA OECD 422 dossier; Canada final assessment).
- cocamidopropyl hydroxysultaine est-il sûr pendant l'allaitement ?
- No data indicating transfer to breastmilk or breastfeeding-specific adverse effects were found in authoritative dossiers or the published toxicology records. Animal studies show no reproductive/developmental hazard at relevant NOAELs; therefore hazard and mechanism scores are 0. Topical use implies low but measurable maternal systemic exposure, so breastfeeding exposure scored as low (e=1).
- cocamidopropyl hydroxysultaine est-il sûr pour la peau de bébé ?
- No infant-specific reproductive/toxic mechanism or developmental evidence was found. Because the ingredient has measurable absorption in systemic toxicity studies (oral) and topical cosmetics can be absorbed to a low extent in adults, infant skin (0–3 yr) — which has an immature barrier and higher surface-area-to-weight ratio — receives one point higher exposure (adult e=1 → baby e=2). No infant-specific hazards were identified in the searched sources.
- Comment VeriMom évalue-t-il cocamidopropyl hydroxysultaine ?
- VeriMom évalue cocamidopropyl hydroxysultaine à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cocamidopropyl hydroxysultaine pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cocamidopropyl hydroxysultaine basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.